Silgan (SLGN) Q4 2024 earnings summary

Executive summary

• Delivered strong 2024 performance with record Q4 adjusted EPS and double-digit free cash flow growth, despite customer de-stocking in H1.

• Closed the Weener Plastics/Packaging acquisition, expanding the Dispensing and Specialty Closures segment and adding a high-margin, growth-oriented business.

• Advanced a $50 million multi-year cost savings initiative, achieving $20 million in 2024 and targeting $30 million in 2025.

• Dispensing and specialty closures segment achieved record results, with three consecutive quarters of double-digit organic growth in dispensing products.

• Announced leadership addition with Philippe Chevrier as EVP and COO.

Financial highlights

• Full year 2024 net sales were $5.85B, down 2% from $5.99B in 2023; Q4 net sales rose 5% year-over-year to $1.41B, driven by the Weener acquisition.

• Adjusted EBIT for Q4 was $151.7 million, up 12% year-over-year, with record segment results; Q4 EBIT was $94.2M, down from $126.1M in Q4 2023.

• Record adjusted EPS of $0.85 in Q4, up 35% from prior year; full year adjusted net income per diluted share for 2024 was $3.62, up 6% from 2023.

• Free cash flow for 2024 was $391.3M, up 10% from $356.7M in 2023.

• Dispensing and specialty closures Q4 sales rose 22%, with $100 million from Weener and 5% higher volume mix.

Outlook and guidance

• 2025 adjusted EPS guidance: $4.00–$4.20, a 13% increase at midpoint over 2024.

• 2025 free cash flow estimated at $450 million, up 15% year-over-year, with CapEx of $300 million.

• Q1 2025 adjusted EPS guidance: $0.74–$0.84, up 14% year-over-year.

• Volumes and Adjusted EBIT in all segments expected to be higher in 2025, with record performance anticipated.